Latest News

The listing below shows our latest News Items and is updated regularly.  If you wish to post a news item please select the 'Post News' button on the right.  The displayed news feed starts on 1st August 2016.  Older items can be found here.

To 'Post Your News' use the button at the top right.



SynbiCITE launches new five-year strategy

SynbiCITE, the UK’s national centre for commercialisation of synthetic biology, is pleased to announce the launch of a new five-year strategy underpinned by a new £5M grant from UKRI and other sources. The new strategy will see the launch of SynbiCITE 2.0, which aims to expand and develop SynbiCITE’s reach within the UK’s synthetic biology innovation and academic ecosystem, and create a single highly interconnected UK innovation cluster.

Read the rest of entry »

Innovate UK Awards OBN Member Medherant a Medicines Manufacturing Grant

Medherant, a developer of innovative transdermal drug delivery treatments for pain and CNS diseases, has been awarded a Medicines Manufacturing Grant by Innovate UK. The grant will enable the Company to buy equipment and move forward with its plans to extend its pilot scale manufacture of patches formulated with its unique TEPI Patch® technology to GMP manufacture for clinical trials.

Read the rest of entry »

Isansys Lifecare named as one of the top companies in the UK which could help save the NHS millions

Isansys Lifecare's Patient Status Engine wireless patient monitoiring platform could help deliver millions of pounds worth of savings to the NHS.

Read the rest of entry »

Thermo Fisher Scientific brought Science World successfully back to Manchester

Science World, the Fisher Scientific Laboratory Experience, made its successful return to Emirates Old Trafford – Lancashire County Cricket Club, Manchester on 27 September. The event, hosted by Thermo Fisher Scientific, showcased the latest in laboratory innovations available through Fisher Scientific.

Read the rest of entry »

Scotland’s Life Sciences Start-Ups to benefit from BioCity’s specialist support

Life sciences incubator, BioCity, has won a contract tendered by Scottish Enterprise to provide specialist support and advice to all its life science start-ups in Scotland.The minimum three-year contract will see BioCity provide specialist coaches and consultants to help and support the next generation of life science start-ups in Scotland to achieve their potential.

Read the rest of entry »

BioHub Birmingham® develops new incubator space to meet increasing demand for biomedical facilities

The BioHub Birmingham® is constructing 5,000sq ft of self-contained laboratory and office suites to meet an increasing demand for biomedical incubator space.

The BioHub opened in 2015 and its shared facilities on the ground floor are now operating at capacity. It is managed by University of Birmingham Enterprise and is located at the Birmingham Research Park, which provides incubation services and facilities, as well as commercial office space for biomedical and hi-tech companies. 

Read the rest of entry »

Oxford MEStar wins funding to develop 3D printed medical implants

Oxford MEStar, the Oxford University bioengineering spinout company, today announced that it has been awarded funding to take part in a 36-month, € 6.84 Million project under the EU Interreg 2 Seas initiative. 

Read the rest of entry »

Government Confirms £1bn Funding for British Innovation

CPI has received a share of £1bn Government funding to support next-generation manufacturing work across the High Value Manufacturing Catapult programme.

Read the rest of entry »

Diamond Pharma Services shortlisted for two prestigious industry awards.

Diamond are proud to announce that they have been shortlisted in two categories in the TOPRA (The Organisation for Professionals in Regulatory Affairs) awards recognising their commitment to innovation and excellence in customer service.

Read the rest of entry »

Discovery follows successful collaboration between Selcia, Cypralis and Gilead Sciences

On Monday 17 September 2018 OBN Members Selcia and Cypralis announced that their collaboration with Gilead has resulted in the identification of synthetic, macrocyclic, orally bioavailable cyclophilin inhibitors with potent HCV activity. 

Read the rest of entry »

Search Posts

News Policy

OBN aims to provide sector NEWS that is relevant to our Membership. We filter information from a variety of sources, publish items ourselves and will publish items of News from our Members. Press releases about OBN can be found here.